Antioxidants in Alzheimer’s disease: Current therapeutic significance and future prospects P Pritam, R Deka, A Bhardwaj, R Srivastava, D Kumar, AK Jha, NK Jha, ... Biology 11 (2), 212, 2022 | 60 | 2022 |
Silybin B and cianidanol inhibit Mpro and spike protein of SARS-CoV-2: Evidence from in silico molecular docking studies R Srivastava, S Tripathi, S Unni, A Hussain, S Haque, N Dasgupta, ... Current pharmaceutical design 27 (32), 3476-3489, 2021 | 18 | 2021 |
Advances in pulmonary drug delivery targeting microbial biofilms in respiratory diseases A Sharma, D Kumar, K Dahiya, S Hawthorne, SK Jha, NK Jha, P Nand, ... Nanomedicine 16 (21), 1905-1923, 2021 | 11 | 2021 |
Evolution of extraction technique for the separation of bioactive compounds from Aegle marmelos R Srivastava, JV Parambil Separation Science and Technology 58 (4), 667-681, 2023 | 1 | 2023 |
Advances in stromal cell therapy for management of Alzheimer’s disease R Srivastava, A Li, T Datta, NK Jha, S Talukder, SK Jha, ZS Chen Frontiers in Pharmacology 13, 955401, 2022 | 1 | 2022 |
Enhancement of Biohydrogen Production by the Application of Microbial Nanotechnology T Datta, A Ahmed, SK Jha, R Srivastava, P Singh, B Naik Bionanotechnology Towards Green Energy, 275-294, 2023 | | 2023 |
Exploring state-of-the-art advances in targeted nanomedicines for managing acute and chronic inflammatory lung diseases S Maurya, R Srivastava, S Arfin, S Hawthorne, NK Jha, K Agrawal, S Raj, ... Nanomedicine 17 (30), 2245-2264, 2022 | | 2022 |